Retracted: Herpes simplex virus 2 infection in HIV seropositive individuals in Tamil Nadu, India
Keywords:HSV-2, HIV, Seroprevalence, Tamil Nadu
AbstractThis article has been retracted due to duplicate publication.
The following article from International Journal of Community Medicine and Public Health, ‘Herpes simplex virus 2 infection in HIV seropositive individuals in Tamil Nadu, India’ (Int J Community Med Public Health. 2015;2(1):33-37, doi: 10.5455/2394-6040.ijcmph20150208), by Saramma Mini Jacob, Thatchinamoorthy Gopal, Sivasangeetha Kanagasabai, Anitha Durairaj, Kamala Mary Sushi, Ganesan Arumugam, was submitted 17th November 2014, accepted on 10th January 2015, and published in the Volume 2, Issue 1, February 2015. While the review was in progress, a duplicate version of the article was published online in the International Journal of Medical Science and Public Health (Int J Med Sci Public Health. 2015;4(3):404-407, doi: 10.5455/ijmsph.2015.1411201483). The authors have apologized to the Editors for this incident, which violated the policies and practices of the International Journal of Community Medicine and Public Health.
Schiffer JT, Corey L. New concepts in understanding genital herpes. Curr Infect Dis Rep. 2009;11(6):457-64.
Bush LM, Talledo-Thais K, Casal-Fernandez A, Perez MT. Resistant herpes simplex virus infection and HIV: a potential diagnostic and therapeutic dilemma. Lab Med. 2011;42:452-7.
Agabi YA, Banwat EB, Mawak JD, Lar PM, Dashe N, Dashen MM, et al. Seroprevalence of herpes simplex virus type-2 among patients attending the sexually transmitted infections clinic in Jos, Nigeria. J Infect Dev Ctries. 2010;4(9):572-5.
Baeten JM, Celum C. Herpes simplex virus and HIV-1. Available at: http://hivinsite.ucsf.edu/InSite?page=kb-05-03-02.
Xu F, Sternberg MR, Gottlieb SL, Berman SM, Markowitz LE, Forhan SE. Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years-United States, 2005-2008. MMMR. Morb Mortal Wkly Rep. 2010;59(15):456-9.
Cunningham AL, Taylor R, Taylor J, Marks C, Shaw J, Mindel A. Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey. Sex Transm Infect. 2006;82(2):164-8.
Mawak JD, Dashe N, Atseye A, Agabi Y, Zakeri H. Seroprevalence and co-infection of herpes simplex virus type 2 and human immunodeficiency virus in Nigeria. Shiraz E-Med J. 2012;13(1):33-9.
Lin H, He N, Su M, Feng J, Chen L, Gao M. Herpes simplex virus infections among rural residents in eastern China. BMC Infect Dis. 2011;11:69.
Schneider JA, Lakshmi V, Dandona R, Kumar GA, Sudha T, Dandona L. Population-based seroprevalence of HSV-2 and syphilis in Andhra Pradesh state of India. BMC Infect Dis. 2010;10:59.
Sgaier SK, Mony P, Jayakumar S, McLaughlin C, Arora P, Kumar R, et al. Prevalence and correlates of herpes simplex virus-2 and syphilis infections in the general population in India. Sex Transm Infect. 2011;87(2):94-100.
Sripriya M, Rajendran P, Seethalakshmi I, Karthikeyan M, Gnanasekaran AG, Kannan M, et al. Herpes simplex virus type-2 infection and associated risk factors among weaver’s community in Tamil Nadu state, India. Curr Res Microbiol Biotechnol. 2013;1(4):143-7.
Bochner AF, Madhivanan P, Niranjankumar B, Ravi K, Arun A, Krupp K, et al. The epidemiology of herpes simplex virus type-2 infection among pregnant women in rural Mysore taluk, India. J Sex Transm Dis. 2013;2013:750415.
World Health Organization: Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance; African region. Geneva: WHO; 2005. Available at: http://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf.
Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ. 2008;86(10):805-12.
Mugo N, Dadabhai SS, Bunnell R, Williamson J, Bennett E, Baya I, et al. Prevalence of herpes simplex virus type 2 infection, human immunodeficiency virus/herpes simplex virus type 2 coinfection, and associated risk factors in a national, population-based survey in Kenya. Sex Transm Dis. 2011;38(11):1059-66.
Rode OD, Lepej SZ, Begovac J. Seroprevalence of herpes simplex virus type 2 in adult HIV-infected patients and blood donors in Croatia. Coll Antropol. 2008;32(3):693-5.
Anuradha K, Singh HM, Gopal KVT, Rao GRR, Ramani TV, Padmaja J. Herpes simplex virus 2 infection: a risk factor for HIV infection in heterosexuals. Indian J Dermatol Venereol Leprol. 2008;74:230-3.
Venkateshwaran SP, Murugesan K, Sivaraj R. Seroprevalence of IgG and IgM antibodies in individuals with herpes simplex virus-1 & 2 infection in HIV positive and negative individuals of South Indian population. J Appl Pharmaceut Sci. 2011;10(1):154-8.
Chakraborty N, Bhattacharyya S, De C, Mukherjee A, Bhattacharya D, Santra S, et al. Incidence of multiple Herpes virus infection in HIV seropositive patients, a big concern for Eastern Indian scenario. Virol J. 2010;7:147-53.
Karad AB, Khade SL. Seroepidemiological study of herpes simplex virus type 2 infection in HIV positive patients, Delhi, India, 2007. Int J Med Public Health. 2013;3:168-72.
Hill C, McKinney E, Lowndes CM, Munro H, Murphy G, Parry JV, et al. Epidemiology of herpes simplex virus types 2 and 1 amongst men who have sex with men attending sexual health clinics in England and Wales: implications for HIV prevention and management. Euro Surveill. 2009;14:34-9.
Schaftenaar E, Verjans GMGM, Getu S, McIntyre JA, Struthers HE, Osterhaus ADME, et al. High Seroprevalence of human herpes viruses in HIV-infected patients attending primary healthcare facilities in rural South Africa. PLoS One. 2014;9(6):e99243.
Nakubulwa S, Mirembe FM, Kaye DK, Kaddu-Mulindwa D. Association between HSV 2 and HIV serostatus in pregnant women of known HIV serostatus attending Mulago hospital antenatal clinic, Kampala, Uganda. J Infect Dev Ctries. 2009;3(10):803-6.
Celum C, Wald A, Lingappa JR, Magaret JS, Wang RS, Mugo N, et al. Acyclovir and transmission of HIV-1 from persons who are infected with HIV-1 and HSV-2. N Engl J Med. 2010;362:427-39.
Anzivino E, Fioriti D, Mischitelli M, Bellizzi A, Barucca V, Fernanda Chiarini, et al. Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention. Virol J. 2009;(6):40.
Augenbraun M, Feldman J, Chirgwin K, Zenilman J, Clarke L, DeHovitz J, et al. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Int Med. 1995;123:845-7.
Posavad CM, Koelle DM, Shaughnessy MF, Corey L. Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses. Proc Natl Acad Sci U S A. 1997;94(19):10289-94.
Allen PS, Das S. Prevalence of HSV-1/HSV-2 antibodies in HIV seropositive patients in Coventry, United Kingdom. Sex Transm Infect. 2004;80:77.
Muiru AN, Guthrie BL, Bosire R, Merkel M, Liu AY, Choi RY, et al. Incident HSV-2 infections are common among HIV-1-discordant couples. J Infect Dis. 2013;208:1093-101.
Patterson J, Hitti J, Selke S, Huang ML, Watts H, Brown Z, et al. Genital HSV detection among HIV-1 infected pregnant women in labor. Infect Dis Obstet Gynecol. 2011;2011:1-4.
Arama V, Cercel AS, Vladareanu R, Mihai C, Mihailescu R, Rankin J, et al. Type-specific herpes simplex virus-1 and herpes simplex virus-2 seroprevalence in Romania: comparison of prevalence and risk factors in women and men. Int J Infect Dis. 2010;14(Suppl 3):e25-31.
Johnston C, Koelle DM, Wald A. HSV-2: in pursuit of a vaccine. J Clin Invest. 2011;121(12):4600-9.
Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ. 2008;86:805-12.
Tan DHS, Raboud JM, Kaul R, Walmsley SL. Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV co-infected adults: an observational cohort study. BMJ Open. 2014;4:e004210.
McMahon MA, Parsons TL, Siliciano RF. Consistent inhibition of HIV-1 replication in CD4+ T cells by acyclovir without detection of human herpes viruses. J Virol. 2011;85(9):4818-22.
Tan DHS, Raboud JM, Kaul R, Grinsztejn B, Cahn P, Walmsley SL. Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VAL-acyclovir in delaying antiretroviral treatment entry (VALIDATE) trial. Trials. 2010;11:113.